City Sounds Alarm on £40bn Foreign M&A Offensive Targeting ‘Cheap’ UK Firms

Why It Matters

These acquisitions strip the London market of blue‑chip listings, reducing liquidity and undermining the UK’s ability to fund growth domestically. Accelerating delistings also pressure regulators to reform pension‑fund investment rules and tax incentives to retain capital at home.

Key Takeaways

• Foreign firms targeting UK listed companies total $51bn in offers this year
• Tate & Lyle received $3.4bn bid from US rival Ingredion
• EQT raised Intertek offer to $13.5bn, a 62% premium
• UK equities trade at ~15x earnings versus 32x in US S&P 500
• Regulators urged to boost pension fund investment in domestic small‑cap stocks

Pulse Analysis

The United Kingdom’s equity market is becoming a prime hunting ground for overseas investors, driven by a stark valuation gap with U.S. peers. London‑listed firms average roughly 15‑times earnings, half the multiple of the S&P 500, prompting U.S. asset managers and private‑equity houses to pursue cut‑price take‑private transactions. This pricing disparity stems from lingering post‑Brexit uncertainty, higher compliance costs, and a perception that UK companies are undervalued relative to their growth prospects.

Recent headlines illustrate the scale of the trend. US ingredient giant Ingredion offered $3.4 billion for sugar‑maker Tate & Lyle, while EQT lifted its bid for Intertek to $13.5 billion, representing a 62% premium over the pre‑bid price. Other marquee deals—Zurich’s 60% premium for insurer Beazley and Nuveen’s $12.7 billion acquisition of Schroders—underscore how foreign capital is willing to pay sizable premiums to secure footholds in the UK market. For shareholders, the upside is immediate cash, but the broader consequence is a shrinking pool of publicly listed companies that can attract institutional capital.

Policymakers now face a strategic dilemma: stem the outflow of listings or accept a leaner market structure. Industry leaders argue for reforms that make UK equities more attractive, such as easing the tax burden on pension‑fund allocations to domestic small‑cap stocks and simplifying the regulatory regime for public companies. The Mansion House Accord already nudges pension funds to allocate 10% of assets to private and small‑cap equities, but execution remains uneven. Strengthening these incentives could preserve capital within Britain, sustain market depth, and protect the long‑term financing engine essential for corporate growth. Without decisive action, the UK risks ceding its equity market relevance to more lucrative overseas venues.